Wednesday, July, 24, 2019 04:25:45

Contribution By Ojaswita Kutepatil


Staten & Novo Nordisk partner to develop dyslipidaemia treatment

Forbion, a healthcare venture capital firm with centers in Germany and the Netherlands, recently announced that its portfolio company Staten Biotechnology B.V. and Denmark-based healthcare company Novo Nordisk A/S have collaborated and signed an exclusive option agreement in a bid to develop new therapeutics hypertriglyceridaemia …

NSF and Internet2 aiming to accelerate science using cloud computing

Reports confirm that the National Science Foundation (NSF) has inked a new cooperative agreement with nonprofit computer networking consortium Internet2. The collaboration is supposedly aimed at partnering with providers of commercial cloud computing and to support scientific applications in new, more effective uses of the …